Brijjit Force Modulating Tissue Bridge

About BRIJ Medical

BRIJ Medical, founded in 2018, has developed and commercialized the Brijjit Force Modulating Tissue Bridge, a novel medical device that actively offloads tension from surgical incisions to promote better healing. The company targets the plastic and reconstructive surgery, orthopedic surgery, and urgent care markets with a product clinically demonstrated to significantly reduce wound breakdown and scar size. BRIJ Medical operates as a commercial-stage, private company, generating revenue through direct sales of its FDA-cleared Class I medical device to healthcare providers and systems.

Therapeutic Areas